ChaLearn Looking at People and Faces of the World: Face AnalysisWorkshop and Challenge 2016

We present the 2016 ChaLearn Looking at People and Faces of the World Challenge and Workshop, which ran three competitions on the common theme of face analysis from still images. The first one, Looking at People, addressed age estimation, while the second and third competitions, Faces of the World, addressed accessory classification and smile and gender classification, respectively. We present two crowd-sourcing methodologies used to collect manual annotations. A custom-build application was used to collect and label data about the apparent age of people (as opposed to the real age). For the Faces of the World data, the citizen-science Zooniverse platform was used. This paper summarizes the three challenges and the data used, as well as the results achieved by the participants of the competitions. Details of the ChaLearn LAP FotW competitions can be found at http://gesture.chalearn.org

An outbreak of hantavirus pulmonary syndrome, Chile, 1997

Fil: Toro, Jorge. Ministry of Health; Chile.Fil: Vega, Jeanette D. Pan American Health Organization; Chile.Fil: Khan, Ali S. Centers for Disease Control and Prevention; Estados Unidos.Fil: Mills, James N. Centers for Disease Control and Prevention; Estados Unidos.Fil: Padula, Paula. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Terry, William. Centers for Disease Control and Prevention; Estados Unidos.Fil: Yadón, Zaida. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Valderrama, Rosa. Aysen Region XI Health Service; Chile.Fil: Ellis, Barbara A. Centers for Disease Control and Prevention; Estados Unidos.Fil: Pavletic, Carlos. Ministry of Health; Chile.Fil: Cerda, Rodrigo. Pan American Health Organization; Chile.Fil: Zaki, Sherif. Centers for Disease Control and Prevention; Estados Unidos.Fil: Wun-Ju, Shieh. Centers for Disease Control and Prevention; Estados Unidos.Fil: Meyer, Richard. Centers for Disease Control and Prevention; Estados Unidos.Fil: Tapia, Mauricio. Coyhaique Regional Hospital; Chile.Fil: Mansilla, Carlos. Coyhaique Regional Hospital; Chile.Fil: Baro, Michel. Llanchipal Health Services; Chile.Fil: Vergara, Jose A. Llanchipal Health Services; Chile.Fil: Concha, Marisol. Ministry of Health; Chile.Fil: Calderón, Gladys. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Peters, C.J. Centers for Disease Control and Prevention; Estados Unidos.Fil: Ksiazek, Thomas G. Centers for Disease Control and Prevention; Estados Unidos.An outbreak of 25 cases of Andes virus-associated hantavirus pulmonary syndrome (HPS) was recognized in southern Chile from July 1997 through January 1998. In addition to the HPS patients, three persons with mild hantaviral disease and one person with asymptomatic acute infection were identified. Epidemiologic studies suggested person-to-person transmission in two of three family clusters. Ecologic studies showed very high densities of several species of sigmodontine rodents in the area

An outbreak of hantavirus pulmonary syndrome, Chile, 1997

Fil: Toro, Jorge. Ministry of Health; Chile.Fil: Vega, Jeanette D. Pan American Health Organization; Chile.Fil: Khan, Ali S. Centers for Disease Control and Prevention; Estados Unidos.Fil: Mills, James N. Centers for Disease Control and Prevention; Estados Unidos.Fil: Padula, Paula. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Terry, William. Centers for Disease Control and Prevention; Estados Unidos.Fil: Yadón, Zaida. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Valderrama, Rosa. Aysen Region XI Health Service; Chile.Fil: Ellis, Barbara A. Centers for Disease Control and Prevention; Estados Unidos.Fil: Pavletic, Carlos. Ministry of Health; Chile.Fil: Cerda, Rodrigo. Pan American Health Organization; Chile.Fil: Zaki, Sherif. Centers for Disease Control and Prevention; Estados Unidos.Fil: Wun-Ju, Shieh. Centers for Disease Control and Prevention; Estados Unidos.Fil: Meyer, Richard. Centers for Disease Control and Prevention; Estados Unidos.Fil: Tapia, Mauricio. Coyhaique Regional Hospital; Chile.Fil: Mansilla, Carlos. Coyhaique Regional Hospital; Chile.Fil: Baro, Michel. Llanchipal Health Services; Chile.Fil: Vergara, Jose A. Llanchipal Health Services; Chile.Fil: Concha, Marisol. Ministry of Health; Chile.Fil: Calderón, Gladys. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas Dr. Julio Maiztegui; Argentina.Fil: Peters, C.J. Centers for Disease Control and Prevention; Estados Unidos.Fil: Ksiazek, Thomas G. Centers for Disease Control and Prevention; Estados Unidos.An outbreak of 25 cases of Andes virus-associated hantavirus pulmonary syndrome (HPS) was recognized in southern Chile from July 1997 through January 1998. In addition to the HPS patients, three persons with mild hantaviral disease and one person with asymptomatic acute infection were identified. Epidemiologic studies suggested person-to-person transmission in two of three family clusters. Ecologic studies showed very high densities of several species of sigmodontine rodents in the area

SARS-CoV-2 E and 3a proteins are inducers of pannexin currents

Controversial reports have suggested that SARS-CoV E and 3a proteins may be viroporins that conduct currents through the plasma membrane of the infected cells. If true, these proteins would represent accessible targets for the development of new antiviral drugs by using high-throughput patch-clamp techniques. Here we aimed at better characterizing the cell responses induced by E or 3a protein with a particular focus on the ion conductances measured at the cell surface. First, we show that expression of SARS-CoV-2 E or 3a protein in CHO cells gives rise to cells with newly-acquired round shape, tending to detach from the Petri dish. This suggests that cell death is induced upon expression of E or 3a protein. We confirmed this hypothesis by using flow cytometry, in agreement with earlier reports on other cell types. In adhering cells expressing E or 3a protein, whole-cell currents were in fact not different from the control condition indicating that E and 3a proteins are not plasma membrane viroporins. In contrast, recording currents on detached cells uncovered outwardly-rectifying currents, much larger than those observed in control. The current characteristics are reminiscent of what was previously observed in cells expressing SARS-CoV-1 E or 3a proteins. Herein, we illustrate for the first time that carbenoxolone blocks these outward currents suggesting that they are conducted by pannexin channels, mostly likely activated by cell morphology change and/or cell death. Alongside we also demonstrate that truncation of the C-terminal PDZ binding motifs reduces the proportion of dying cells but does not prevent pannexin currents suggesting distinct pathways for cell death and pannexin currents induced by E and 3a proteins. We conclude that SARS-CoV-2 E and 3a proteins are not acting as viroporins expressed at the plasma membrane